525 related articles for article (PubMed ID: 29766345)
21. Visual evoked potentials in konzo, a spastic paraparesis of acute onset in Africa.
Mwanza JC; Lysebo DE; Kayembe DL; Tshala-Katumbay D; Nyamabo LK; Tylleskär T; Plant GT
Ophthalmologica; 2003; 217(6):381-6. PubMed ID: 14573969
[TBL] [Abstract][Full Text] [Related]
22. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials.
North K; Cochineas C; Tang E; Fagan E
Pediatr Neurol; 1994 Mar; 10(2):117-23. PubMed ID: 8024659
[TBL] [Abstract][Full Text] [Related]
23. The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.
Tekavčič Pompe M; Pečarič Meglič N; Šuštar Habjan M
Doc Ophthalmol; 2023 Apr; 146(2):121-136. PubMed ID: 36652041
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of optic nerve functions in subacute combined degeneration using visual evoked potential and diffusion tensor imaging-a pilot study.
Kalita J; Soni N; Dubey D; Kumar S; Misra UK
Br J Radiol; 2018 Nov; 91(1091):20180086. PubMed ID: 29987983
[TBL] [Abstract][Full Text] [Related]
25. Visual evoked potentials in diabetic teen-agers: influence of metabolic control and relationship with peripheral neuropathy.
Comi G; Martinelli V; Galardi G; Medaglini S; Poggi A; Beccaria L; Meschi F; D'Arcais AF
Metab Pediatr Syst Ophthalmol (1985); 1986; 9(2-4):85-7. PubMed ID: 3452014
[TBL] [Abstract][Full Text] [Related]
26. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG
Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406
[TBL] [Abstract][Full Text] [Related]
27. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
28. Pattern visual evoked potential and foveal sensitivity in amblyopia.
Dahal M; Dahal HN; Gautam P; Shrestha JB; Khanal S
Doc Ophthalmol; 2023 Oct; 147(2):109-119. PubMed ID: 37639170
[TBL] [Abstract][Full Text] [Related]
29. Retinal function and neural conduction along the visual pathways in affected and unaffected carriers with Leber's hereditary optic neuropathy.
Ziccardi L; Sadun F; De Negri AM; Barboni P; Savini G; Borrelli E; La Morgia C; Carelli V; Parisi V
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6893-901. PubMed ID: 24071953
[TBL] [Abstract][Full Text] [Related]
30. Evoked potentials in diagnosis of visual dysfunction in amateur boxers.
Lesiakowski P; Lubiński W; Zwierko T
Phys Sportsmed; 2018 Nov; 46(4):449-459. PubMed ID: 29973091
[TBL] [Abstract][Full Text] [Related]
31. Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas.
Hepokur M; Sarici AM
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1757-1765. PubMed ID: 29754292
[TBL] [Abstract][Full Text] [Related]
32. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA
Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
[TBL] [Abstract][Full Text] [Related]
33. Pattern-reversal visual evoked potentials as a diagnostic tool for ocular malingering.
Soares TS; Sacai PY; Berezovsky A; Rocha DM; Watanabe SE; Salomão SR
Arq Bras Oftalmol; 2016; 79(5):303-307. PubMed ID: 27982208
[TBL] [Abstract][Full Text] [Related]
34. Influence of visual angle on pattern reversal visual evoked potentials.
Kothari R; Singh S; Singh R; Shukla AK; Bokariya P
Oman J Ophthalmol; 2014 Sep; 7(3):120-5. PubMed ID: 25378875
[TBL] [Abstract][Full Text] [Related]
35. Optic Pathway Gliomas in Neurofibromatosis Type 1.
Campen CJ; Gutmann DH
J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
[TBL] [Abstract][Full Text] [Related]
36. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
[TBL] [Abstract][Full Text] [Related]
37. Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Ullrich NJ; Prabhu SP; Packer RJ; Goldman S; Robison NJ; Allen JC; Viskochil DH; Gutmann DH; Perentesis JP; Korf BR; Fisher MJ; Kieran MW;
Pediatr Blood Cancer; 2021 Apr; 68(4):e28833. PubMed ID: 33336845
[TBL] [Abstract][Full Text] [Related]
38. Monitoring visual function in children with syndromic craniosynostosis: a comparison of 3 methods.
Liasis A; Nischal KK; Walters B; Thompson D; Hardy S; Towell A; Dunaway D; Jones B; Evans R; Hayward R
Arch Ophthalmol; 2006 Aug; 124(8):1119-26. PubMed ID: 16908814
[TBL] [Abstract][Full Text] [Related]
39. Pattern reversal visual evoked potentials in adults: variability with age.
Sawaya R; Sawaya H; Youssef G
Clin Invest Med; 2017 Dec; 40(6):E252-E259. PubMed ID: 29256391
[TBL] [Abstract][Full Text] [Related]
40. Relative value of the inion and mid-parietal locations as additional recording sites in pattern reversal visual evoked potentials.
Beydoun A; Drury I; Vanderzant C
Electroencephalogr Clin Neurophysiol; 1997 Jul; 104(4):369-74. PubMed ID: 9246075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
